泰格医药 (300347.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(泰格医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年三季报2024年中报2024年一季报2023年年报2023年三季报2023年中报2023年一季报
主要指标:
 营业收入(元) 5,067,615,359.893,358,244,223.391,660,204,321.447,384,039,460.885,650,477,938.013,710,850,371.591,804,571,375.28
 营业利润(元) 1,084,995,900.89687,069,420.22362,196,228.412,486,940,557.422,311,724,272.621,598,597,788.22630,897,782.90
 利润总额(元) 1,087,064,971.75690,093,172.97362,364,203.952,488,533,058.162,314,469,415.051,599,145,093.00631,062,128.03
 净利润(元) 903,135,476.96557,578,693.92312,570,373.392,149,926,843.572,027,846,971.741,408,089,992.74568,325,660.27
 归属于母公司股东的净利润(元) 813,428,915.46492,848,850.97235,072,002.702,024,849,989.111,879,604,430.161,388,337,006.20568,455,092.87
盈利能力:
 销售毛利率(%) 38.8839.6937.8338.5840.3439.9139.65
 销售净利率(%) 17.8216.6018.8329.1235.8937.9531.49
 净资产收益率(%) 3.862.381.14----
 总资产报酬率ROA(%) 3.712.241.17----
 投入资本回报率ROIC(%) 3.332.010.978.828.136.062.55
营运能力:
 存货周转率(次) 125.3183.2244.11----
 应收账款周转率(次) 4.192.651.45----
 总资产周转率(次) 0.170.110.06----
偿债能力:
 资产负债率(%) 19.3520.8818.4117.6118.3619.2417.23
 股东权益比率(%) 69.5868.2770.2870.8470.0369.3971.51
 已获利息倍数(倍) 35.65-41.84-15.53-21.97-20.88-17.15-38.54
 流动比率 1.371.432.612.742.682.582.95
 速动比率 1.301.382.542.672.622.522.88
发展能力:
 营业收入增长率(%) -10.32-9.50-8.004.214.523.25-0.73
 营业利润增长率(%) -53.07-57.02-42.59-3.7015.537.95-3.59
 税后利润增长率(%) -56.72-64.50-58.650.9117.1316.479.65
 净资产增长率(%) 0.020.874.907.379.7410.359.45
 总资产增长率(%) 0.682.536.748.1410.8015.4213.58

前瞻产业研究院